Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloquet: Haloperidol vs Quetiapine vs Placebo for Delirium
NCT01811459Phase 3Completed
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Feb 2013
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine (extended-release tablet, brand name: Bipresso), haloperidol in delirium, sponsored by Centre hospitalier de l’Université de Montréal. Started Feb 2013; status: completed.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)haloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on NCT01811459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01811459.